Yesterday’s US approval of idelalisib, Gilead Sciences’ first oncology drug, should have been a ...
July 24, 2014
Many companies would give a great deal to know what methods of persuasion Proteus Digital Health is ...
Jakafi's failure to prove that it can control polycythaemia vera (PV) symptoms better than ...
July 21, 2014
June 17, 2014
June 10, 2014
April 17, 2014
Huge second quarter for M&A sets 2014 on track for record year
Exelixis shares surge on positive melanoma data
Big-cap medtech up across the board during eventful first half
Ireland tax shelter beckons for Salix
Big Pharma Becomes a Smaller Employer While Biotech Booms
Pharma & Biotech 2013 in Review
Medtech 2013 in Review
Terms & Conditions
Follow us on Twitter